Seeking Alpha

Pfizer's (PFE) Zyvox antibiotic was effective in combating a highly drug-resistant and deadly...

Pfizer's (PFE) Zyvox antibiotic was effective in combating a highly drug-resistant and deadly form of tuberculosis called XDR-TB when added to patients' existing treatments. However, 82% of patients experienced side effects such as lower red and while blood cell counts, and damage to the optic and peripheral nerves. The side effects diminished when the drug dose was reduced or ended.
From other sites
Comments (1)
  • Drew Robertson
    , contributor
    Comments (330) | Send Message
     
    The good news is that you aren't going to die from TB. However there is some bad news but right now I have to take this call. I'll get back to you.
    18 Oct 2012, 10:44 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector